Tezspire, Injektionslösung in einer Fertigspritze
7680684540011
CH-68454
Injektionslösung
Associated product:
TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
tezepelumabum
|
210.0 MG | Substance | Wirkstoff (Principe actif) |
|
prolinum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1098.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2023
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68454
- Drug name
- Tezspire, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX11
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 13/06/2022
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.5.
- Domain
- Human medicine
Package details
- Description (FR)
- TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
- Description (DE)
- TEZSPIRE Inj Lös 210 mg/1.91ml Fertspr 1.91 ml
- Market launch
- 13/06/2022
- Narcotic (BTM)
- No